Cost-Effectiveness of the Third-Agent Class in Treatment-Naive Human Immunodeficiency Virus-Infected Patients in Portugal
AuthID
P-00J-TT3
P-00J-TT3
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service